![Gregory D. Plowman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory D. Plowman
Directeur/Bestuurslid bij
New York Biotechnology Association, Inc.
Profiel
Gregory D.
Plowman is currently a Director at New York Biotechnology Association, Inc., AurKa Pharma, Inc., and Acanthas Pharma, Inc. He was previously a Senior Vice President at ImClone LLC, Vice President-Oncology Research at Eli Lilly & Co., and Chief Technology Officer at Exelixis, Inc. Plowman holds a doctorate from the University of Washington and an undergraduate degree from Whitman College.
Actieve functies van Gregory D. Plowman
| Bedrijven | Functie | Begin |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Directeur/Bestuurslid | - |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Bestuurslid | 19-03-2019 |
Eerdere bekende functies van Gregory D. Plowman
| Bedrijven | Functie | Einde |
|---|---|---|
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Directeur/Bestuurslid | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Gregory D. Plowman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitman College
 Whitman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Health Technology |
Acanthas Pharma, Inc.
Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies MarketScreener 
